These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
952 related articles for article (PubMed ID: 22475555)
1. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Cashin PH; Graf W; Nygren P; Mahteme H Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555 [TBL] [Abstract][Full Text] [Related]
2. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814 [TBL] [Abstract][Full Text] [Related]
3. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923 [TBL] [Abstract][Full Text] [Related]
4. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834 [TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813 [TBL] [Abstract][Full Text] [Related]
6. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983 [TBL] [Abstract][Full Text] [Related]
7. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience. Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A J BUON; 2014; 19(1):66-74. PubMed ID: 24659645 [TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771 [TBL] [Abstract][Full Text] [Related]
9. Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no? Williams BH; Alzahrani NA; Chan DL; Chua TC; Morris DL Eur J Surg Oncol; 2014 Aug; 40(8):943-9. PubMed ID: 24378009 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei. Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244 [TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center. Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584 [TBL] [Abstract][Full Text] [Related]
13. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942 [TBL] [Abstract][Full Text] [Related]
14. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596 [TBL] [Abstract][Full Text] [Related]
15. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome. Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis. Klaver YL; Chua TC; de Hingh IH; Morris DL J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124 [TBL] [Abstract][Full Text] [Related]
17. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Maggiori L; Elias D Eur J Surg Oncol; 2010 Jul; 36(7):599-603. PubMed ID: 20605396 [TBL] [Abstract][Full Text] [Related]
18. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction. Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508 [TBL] [Abstract][Full Text] [Related]
19. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Goéré D; Malka D; Tzanis D; Gava V; Boige V; Eveno C; Maggiori L; Dumont F; Ducreux M; Elias D Ann Surg; 2013 Jun; 257(6):1065-71. PubMed ID: 23299520 [TBL] [Abstract][Full Text] [Related]
20. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Chua TC; Morris DL; Esquivel J Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]